The TF-603A/G gene promoter polymorphism and circulating monocyte tissue factor gene expression in healthy volunteers

Thrombosis and Haemostasis

Volumn 91, Issue 2, 2004, Pages 248-254

  Reny, Jean Luc ^a   Laurendeau, Ingrid ^b   Fontana, Pierre ^a   Bièche, Ivan ^b   Dupont, Annabelle ^a   Remones, Véronique ^a   Emmerich, Joseph ^a   Vidaud, Michel ^b   Aiach, Martine ^a   Gaussem, Pascale ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Coagulation; Gene expression; Monocyte; Thrombosis; Tissue factor

Indexed keywords

ADENINE; BLOOD CLOTTING FACTOR 8C; FIBRINOGEN; GUANINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; THROMBOPLASTIN;

ADULT; ARTICLE; BLOOD CLOTTING TIME; BLOOD SAMPLING; CAUCASIAN; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; MONOCYTE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; VENOUS THROMBOEMBOLISM; VOLUNTEER;

EID: 10744227445     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-09-0566     Document Type: Article

References (23)

1. Balasubramanian V, Grabowski E, Bini A, et al.. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood 2002; 100: 2787-92.
2. Falati S, Gross P, Merrill-Skoloff G, et al.. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med 2002; 8: 1175-81.
3. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
4. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21: 1876-90.
5. ten Cate H, Timmerman JJ, Levi M. The pathophysiology of disseminated intravascular coagulation. Thromb Haemost 1999; 82: 713-7.
6. Penn MS, Topol EJ. Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling. Circ Res 2001; 89: 1-2.
7. Mackman N. Regulation of the tissue factor gene. Thromb.Haemost 1997; 78: 747-54.
8. Toschi V, Gallo R, Lettino M, et al.. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95: 594-9.
9. Rauch U, Nemerson Y. Tissue factor, the blood, and the arterial wall. Trends Cardiovasc Med 2000; 10: 139-43.
10. Santucci RA, Erlich J, Labriola J, et al.. Measurement of tissue factor activity in whole blood. Thromb Haemost 2000; 83: 445-54.
11. Semeraro N, Colucci M. Tissue factor in health and disease. Thromb Haemost 1997; 78: 759-64.
12. Arnaud E, Barbalat V, Nicaud V, et al.. Polymorphisms in the 5′ regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Temoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study. Arterioscler Thromb Vasc Biol 2000; 20: 892-8.
13. Dupont A, Fontana P, Bachelot-Loza C, et al.. An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. Blood 2003; 101: 1833-40.
14. Fontana P, Dupont A, Gandrille S, et al.. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 2003; 108: 989-95.
15. Spillert CR, Milazzo VJ, Suval WD, et al.. Hypercoagulability in arterial disease. Angiology 1989; 40: 886-9.
16. Bieche I, Parfait B, Le Doussal V, et al.. Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Res 2001; 61: 1652-8.
17. van Deursen PB, Gunther AW, van Riel CC, et al.. A novel quantitative multiplex NASBA method: application to measuring tissue factor and CD14 mRNA levels in human monocytes. Nucleic Acids Res 1999; 27: e15.
18. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45: 255-68.
19. Osterud B. Tissue factor expression in monocytes: in vitro compared to ex vivo. Thromb Haemost 2000;84:521-2.
20. Guha M, Mackman N. The phosphatidylinositol 3-kinase-akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 2002; 277: 32124-32.
21. Ahrens SE, Oeth P, Renner B, et al.. SNPs in the tissue factor gene and their effect on gene expression. Circulation 2001; 102,#18,suppl II: Abstract 102938.
22. Yan SF, Mackman N, Kisiel W, et al.. Hypoxia/Hypoxemia-Induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis. Arterioscler Thromb Vasc Biol 1999; 19: 2029-35.
23. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000; 95: 1517-32.